img

Global Selumetinib Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Selumetinib Market Research Report 2024

Koselugo (selumetinib) is inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2). MEK1/2 proteins are upstream regulators of the extracellular signal-related kinase (ERK) pathway. Both MEK and ERK are critical components of the RAS-regulated RAF-MEK-ERK pathway, which is often activated in different types of cancers.
According to Mr Accuracy reports’s new survey, global Selumetinib market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Selumetinib market research.
Key manufacturers engaged in the Selumetinib industry include AstraZeneca and Merck etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Selumetinib were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Selumetinib market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Selumetinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca
Merck
Segment by Type
10 mg
25 mg

Segment by Application


Hospitals
Clinics
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Selumetinib report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Selumetinib Market Overview
1.1 Product Overview and Scope of Selumetinib
1.2 Selumetinib Segment by Type
1.2.1 Global Selumetinib Market Value Comparison by Type (2024-2034)
1.2.2 10 mg
1.2.3 25 mg
1.3 Selumetinib Segment by Application
1.3.1 Global Selumetinib Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Selumetinib Market Size Estimates and Forecasts
1.4.1 Global Selumetinib Revenue 2018-2034
1.4.2 Global Selumetinib Sales 2018-2034
1.4.3 Global Selumetinib Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Selumetinib Market Competition by Manufacturers
2.1 Global Selumetinib Sales Market Share by Manufacturers (2018-2023)
2.2 Global Selumetinib Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Selumetinib Average Price by Manufacturers (2018-2023)
2.4 Global Selumetinib Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Selumetinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Selumetinib, Product Type & Application
2.7 Selumetinib Market Competitive Situation and Trends
2.7.1 Selumetinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Selumetinib Players Market Share by Revenue
2.7.3 Global Selumetinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Selumetinib Retrospective Market Scenario by Region
3.1 Global Selumetinib Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Selumetinib Global Selumetinib Sales by Region: 2018-2034
3.2.1 Global Selumetinib Sales by Region: 2018-2023
3.2.2 Global Selumetinib Sales by Region: 2024-2034
3.3 Global Selumetinib Global Selumetinib Revenue by Region: 2018-2034
3.3.1 Global Selumetinib Revenue by Region: 2018-2023
3.3.2 Global Selumetinib Revenue by Region: 2024-2034
3.4 North America Selumetinib Market Facts & Figures by Country
3.4.1 North America Selumetinib Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Selumetinib Sales by Country (2018-2034)
3.4.3 North America Selumetinib Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Selumetinib Market Facts & Figures by Country
3.5.1 Europe Selumetinib Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Selumetinib Sales by Country (2018-2034)
3.5.3 Europe Selumetinib Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Selumetinib Market Facts & Figures by Country
3.6.1 Asia Pacific Selumetinib Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Selumetinib Sales by Country (2018-2034)
3.6.3 Asia Pacific Selumetinib Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Selumetinib Market Facts & Figures by Country
3.7.1 Latin America Selumetinib Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Selumetinib Sales by Country (2018-2034)
3.7.3 Latin America Selumetinib Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Selumetinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Selumetinib Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Selumetinib Sales by Country (2018-2034)
3.8.3 Middle East and Africa Selumetinib Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Selumetinib Sales by Type (2018-2034)
4.1.1 Global Selumetinib Sales by Type (2018-2023)
4.1.2 Global Selumetinib Sales by Type (2024-2034)
4.1.3 Global Selumetinib Sales Market Share by Type (2018-2034)
4.2 Global Selumetinib Revenue by Type (2018-2034)
4.2.1 Global Selumetinib Revenue by Type (2018-2023)
4.2.2 Global Selumetinib Revenue by Type (2024-2034)
4.2.3 Global Selumetinib Revenue Market Share by Type (2018-2034)
4.3 Global Selumetinib Price by Type (2018-2034)
5 Segment by Application
5.1 Global Selumetinib Sales by Application (2018-2034)
5.1.1 Global Selumetinib Sales by Application (2018-2023)
5.1.2 Global Selumetinib Sales by Application (2024-2034)
5.1.3 Global Selumetinib Sales Market Share by Application (2018-2034)
5.2 Global Selumetinib Revenue by Application (2018-2034)
5.2.1 Global Selumetinib Revenue by Application (2018-2023)
5.2.2 Global Selumetinib Revenue by Application (2024-2034)
5.2.3 Global Selumetinib Revenue Market Share by Application (2018-2034)
5.3 Global Selumetinib Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Selumetinib Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Selumetinib Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Selumetinib Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Selumetinib Product Portfolio
6.2.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Selumetinib Industry Chain Analysis
7.2 Selumetinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Selumetinib Production Mode & Process
7.4 Selumetinib Sales and Marketing
7.4.1 Selumetinib Sales Channels
7.4.2 Selumetinib Distributors
7.5 Selumetinib Customers
8 Selumetinib Market Dynamics
8.1 Selumetinib Industry Trends
8.2 Selumetinib Market Drivers
8.3 Selumetinib Market Challenges
8.4 Selumetinib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Selumetinib Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Selumetinib Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Selumetinib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Selumetinib Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Selumetinib Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Selumetinib Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Selumetinib Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Selumetinib Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Selumetinib, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Selumetinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Selumetinib, Product Type & Application
Table 12. Global Key Manufacturers of Selumetinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Selumetinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Selumetinib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Selumetinib Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Selumetinib Sales by Region (2018-2023) & (K Units)
Table 18. Global Selumetinib Sales Market Share by Region (2018-2023)
Table 19. Global Selumetinib Sales by Region (2024-2034) & (K Units)
Table 20. Global Selumetinib Sales Market Share by Region (2024-2034)
Table 21. Global Selumetinib Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Selumetinib Revenue Market Share by Region (2018-2023)
Table 23. Global Selumetinib Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Selumetinib Revenue Market Share by Region (2024-2034)
Table 25. North America Selumetinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Selumetinib Sales by Country (2018-2023) & (K Units)
Table 27. North America Selumetinib Sales by Country (2024-2034) & (K Units)
Table 28. North America Selumetinib Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Selumetinib Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Selumetinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Selumetinib Sales by Country (2018-2023) & (K Units)
Table 32. Europe Selumetinib Sales by Country (2024-2034) & (K Units)
Table 33. Europe Selumetinib Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Selumetinib Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Selumetinib Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Selumetinib Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Selumetinib Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Selumetinib Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Selumetinib Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Selumetinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Selumetinib Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Selumetinib Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Selumetinib Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Selumetinib Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Selumetinib Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Selumetinib Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Selumetinib Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Selumetinib Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Selumetinib Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Selumetinib Sales (K Units) by Type (2018-2023)
Table 51. Global Selumetinib Sales (K Units) by Type (2024-2034)
Table 52. Global Selumetinib Sales Market Share by Type (2018-2023)
Table 53. Global Selumetinib Sales Market Share by Type (2024-2034)
Table 54. Global Selumetinib Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Selumetinib Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Selumetinib Revenue Market Share by Type (2018-2023)
Table 57. Global Selumetinib Revenue Market Share by Type (2024-2034)
Table 58. Global Selumetinib Price (US$/Unit) by Type (2018-2023)
Table 59. Global Selumetinib Price (US$/Unit) by Type (2024-2034)
Table 60. Global Selumetinib Sales (K Units) by Application (2018-2023)
Table 61. Global Selumetinib Sales (K Units) by Application (2024-2034)
Table 62. Global Selumetinib Sales Market Share by Application (2018-2023)
Table 63. Global Selumetinib Sales Market Share by Application (2024-2034)
Table 64. Global Selumetinib Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Selumetinib Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Selumetinib Revenue Market Share by Application (2018-2023)
Table 67. Global Selumetinib Revenue Market Share by Application (2024-2034)
Table 68. Global Selumetinib Price (US$/Unit) by Application (2018-2023)
Table 69. Global Selumetinib Price (US$/Unit) by Application (2024-2034)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Selumetinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AstraZeneca Selumetinib Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Selumetinib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Merck Selumetinib Product
Table 79. Merck Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Selumetinib Distributors List
Table 83. Selumetinib Customers List
Table 84. Selumetinib Market Trends
Table 85. Selumetinib Market Drivers
Table 86. Selumetinib Market Challenges
Table 87. Selumetinib Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Selumetinib
Figure 2. Global Selumetinib Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Selumetinib Market Share by Type in 2024 & 2034
Figure 4. 10 mg Product Picture
Figure 5. 25 mg Product Picture
Figure 6. Global Selumetinib Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Selumetinib Market Share by Application in 2024 & 2034
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Selumetinib Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Selumetinib Market Size (2018-2034) & (US$ Million)
Figure 13. Global Selumetinib Sales (2018-2034) & (K Units)
Figure 14. Global Selumetinib Average Price (US$/Unit) & (2018-2034)
Figure 15. Selumetinib Report Years Considered
Figure 16. Selumetinib Sales Share by Manufacturers in 2024
Figure 17. Global Selumetinib Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Selumetinib Players: Market Share by Revenue in 2024
Figure 19. Selumetinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Selumetinib Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Selumetinib Sales Market Share by Country (2018-2034)
Figure 22. North America Selumetinib Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Selumetinib Sales Market Share by Country (2018-2034)
Figure 26. Europe Selumetinib Revenue Market Share by Country (2018-2034)
Figure 27. Germany Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Selumetinib Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Selumetinib Revenue Market Share by Region (2018-2034)
Figure 34. China Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Selumetinib Sales Market Share by Country (2018-2034)
Figure 45. Latin America Selumetinib Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Selumetinib Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Selumetinib Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Selumetinib Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Selumetinib by Type (2018-2034)
Figure 55. Global Revenue Market Share of Selumetinib by Type (2018-2034)
Figure 56. Global Selumetinib Price (US$/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Selumetinib by Application (2018-2034)
Figure 58. Global Revenue Market Share of Selumetinib by Application (2018-2034)
Figure 59. Global Selumetinib Price (US$/Unit) by Application (2018-2034)
Figure 60. Selumetinib Value Chain
Figure 61. Selumetinib Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries